Product Category
Home > Product Category > POCT quick diagnosis > COVID-19

COVID-19 Saliva Antigen Rapid Test  

An instruction manual
  • Product introduction
    【Product Name】COVID-19 Saliva Antigen Rapid Test  Tigsun COVID-19 Speichel Antigen-Schnelltest
    【Packing】 1, 5, 25 tests / box
    【Storage And Stability】It will keep for 24 months if stored in a cool and dry place at 2~30℃, away from sunlight, moisture, heat and frozen condition. Kit contents are stable until the expiration date printed on the outer box. After opening the package, the kit is effective to be used in 1 hour under room temperature (25℃) and humidity (<60%); Buffer solution should be re-capped in time after use.
     
     
     
     
  • Expected use
            Tigsun COVID-19 Saliva Antigen Rapid Test is used for the qualitative detection of the COVID-19 antigen in human Saliva samples. The antigen detection kit detects the novel coronavirus N protein antigen, which can be detected in the early stage of viral infection and can be used as direct evidence of viral infection. It can be used as an auxiliary diagnostic index in clinical practice.
     
  • Detection principle
            Tigsun COVID-19 Antigen Rapid Test employs immunochromatography technology to detect the SARS-CoV-2 antigen in human saliva specimens.
  • Product advantage
    1. Inexpensive, cost-efficency
    2. Simple to use, saliva samples, no instrument needed
    3. Non-invasive, fast, result in 15 minutes
    4. Accurate and reliable compared to molecular methods
  • Clinical symptoms

            The main infection site of the SARS-CoV-2 is the lower respiratory tract. The incubation period of infection is variable. Common symptoms after infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and difficult breathing. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death.

  • Clinical symptoms
    1. Early supplementary screening of 2019-nCoV infection for clinics, hospitals and CDC.
    2. Screening for resumption of work in public institution and companies.
    3. Screening for suspected population.
    4. Screening for students back to school.